Caplin Point Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Ratio | 4.12 | 3.16 | 3.57 | 4.82 | 4.45 |
Fixed Assets | 2.15 | 2.07 | 1.91 | 1.97 | 1.95 |
Inventory | 9.87 | 9.07 | 11.21 | 15.60 | 20.44 |
Debtors | 4.95 | 5.76 | 7.45 | 6.94 | 3.04 |
Interest Cover Ratio | 3681.58 | 3658.40 | 2443.92 | 2782.22 | 1235.94 |
PBIDTM (%) | 62.01 | 62.86 | 60.33 | 52.30 | 48.18 |
PBITM (%) | 58.72 | 58.53 | 55.48 | 47.42 | 43.53 |
PBDTM (%) | 61.99 | 62.84 | 60.31 | 52.28 | 48.14 |
CPM (%) | 48.41 | 49.72 | 49.17 | 40.46 | 37.02 |
APATM (%) | 45.12 | 45.39 | 44.32 | 35.58 | 32.37 |
ROCE (%) | 28.50 | 28.84 | 28.24 | 29.50 | 30.68 |
RONW (%) | 21.97 | 22.43 | 22.63 | 22.24 | 23.00 |